Clinical Trial Advanced Search

And / Or
 Terms to search for:
use synonyms
 
General Search Tips
If your search cannot find what you are looking you might want to consider these tips:

Criteria languages:
You can phrase your search criteria (medical condition, medicine specified) in any of the site languages. A dictionary of common terms will include translations as synonyms.

Results language:
All results will, however, be shown in their original language.

Trial Location:
The search by location is available for the options "All clinical trials" and "Open trials" only. The name of location should be entered in English or in the country's language. If you would like to find all clinical trials led in a specific location, first enter a general term in English such as "Trial" under "Terms to search for".
Terms to exclude:
 
Trials conducted in:
 

 
Recruitment status:
All clinical trials
Open trials

Trials Results:
Results of completed trials
 
Search
Export
Clear
Receive email alerts
Nothing has been entered in the first input field "Terms to search for".
Enter new query label name
Label :
OK
Cancel

1 2 3 4 5 6 7 8 9 2622 5235
Total results returned: 52345
Title: TARGIT: TARGeted Intraoperative radioTherapy versus postoperative radiotherapy
Infobox
Status: Completed
 
5 May 2013
 
10 Locations
Description: TARGIT: TARGeted Intraoperative radioTherapy versus postoperative radiotherapy
Title: Lymphadenectomy in ovarian neoplasms
Infobox
Status: Ongoing
 
10 October 2008
 
1 Location
Description: Lymphadenectomy in ovarian neoplasms
Title: Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
Infobox
Status: Completed
 
11 November 2012
 
1 Location
Description: This study will determine which of the two following treatment regimens provides greater benefit to patients with peritoneal carcinomatosis (gastrointestinal cancer that has spread throughout the abdomen): - Surgical removal of tumors plus heated chemotherapy during surgery, followed by one dose of chemotherapy 7 to 12 days after surgery, followed 3 weeks later by 4 months of chemotherapy; or - Surgical removal of tumors followed by 4 months of chemotherapy, starting 1 month after surgery. Patients 18 years of age and older with peritoneal carcinomatosis may be eligible for this study. Candidates are screened with a medical history, physical examination, and blood tests; chest X-ray and computed tomography (CT) scans; review of pathology slides; electrocardiogram (EKG), bone scan, and brain magnetic resonance imaging (MRI), as needed; and laparotomy. Laparatomy is a surgical procedure in which an incision is made in the abdomen to look at the amount and location of tumors in the abdominal cavity. Patients whose surgery reveals that the tumors cannot be removed are taken off study. Those eligible for the study have their tumors removed during this screening laparotomy as part of the study procedure, as follows: All participants undergo laparotomy and removal of as much tumor as possible, as described above. Patients are then randomly assigned to one of two treatment groups: - Group 1 - During laparotomy, after tumor removal, patients receive continuous hyperthermic peritoneal perfusion (CHPP) with the anti-cancer drug cisplatin. For CHPP, the cisplatin solution is heated and delivered to the abdomen through a catheter (plastic tube), washed through the abdomen for 90 minutes, and then drained out of the body through another catheter. At the close of surgery, a small catheter, called a Tenckhoff catheter, is left in the abdomen and brought out through the skin. Between days 7 and 12 after surgery, one dose of fluorouracil and paclitaxel chemotherapy is delivered through this catheter. The catheter is removed following complete recovery from surgery and the patient is discharged from the hospital. Four to 6 weeks after the surgery, patients have CT scans of the chest, pelvis, and abdomen, and then begin intravenous (IV, through a vein) chemotherapy with oxaliplatin, 5-fluorouracil (5-FU), and leucovorin. The chemotherapy is given in 4-week courses as follows: oxaliplatin on day 1, infused over 2 hours through a vein in the arm or neck; leucovorin on days 1 and 2, infused over 2 hours, followed by 5-fluorouracil over 22 hours; leucovorin and 5-FU repeated two weeks later on days 15 and 16. This regimen is repeated two weeks later. Between each week of chemotherapy is a week break. A course of chemotherapy consists of 28 days (two weeks of chemotherapy and two 1-week breaks). Patients may receive up to four courses (total of 16 weeks) unless their disease progresses or they cannot tolerate further doses. Doses of the chemotherapy can be reduced if the side effects are too severe. - Group 2 - Patients follow the same procedure as those in Group 1 for laparotomy, CT imaging, and IV chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin. They do not receive CHPP or chemotherapy into the abdomen. All patients undergo repeat imaging tests six weeks after surgery and at the conclusion of the intravenous (IV) chemotherapy. They return for a physical examination and CT scans every three months for the first year, every four months for the next two years, and then every six months for up to five years after treatment. They are also asked to complete quality of life questionnaires before and after surgery, at the completion of chemotherapy, and at every follow-up visit.
1 2 3 4 5 6 7 8 9 2622 5235

myPortal

You are a patient?
Gain a better understanding of clinical trials through personalized information.

You are a physician?
Advise and guide your patients with updated data on clinical trials.

 

Save Time

Save time and resources with free myPortal email alerts, specifically defined to meet your needs.

  • Save your search
  • Repeat your search
  • Receive an email when a new matching trial is posted